Drug Shortage Report for GLUCONORM 1.0MG
Report ID | 98703 |
Drug Identification Number | 02239925 |
Brand name | GLUCONORM 1.0MG |
Common or Proper name | Repaglinide |
Company Name | NOVO NORDISK CANADA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | REPAGLINIDE |
Strength(s) | 1.0MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 90 |
ATC code | A10BX |
ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2019-11-15 |
Actual start date | |
Estimated end date | 2019-12-06 |
Actual end date | 2019-11-29 |
Shortage status | Resolved |
Updated date | 2019-11-30 |
Company comments | 1-800-465-4334 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 101-2476 ARGENTIA ROAD MISSISSAUGA, ONTARIO CANADA L5N 6M1 |
Company contact information | 1 800 465 4334 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2019-11-30 | English | Compare |
v7 | 2019-11-29 | French | Compare |
v6 | 2019-11-29 | English | Compare |
v5 | 2019-11-18 | French | Compare |
v4 | 2019-11-18 | English | Compare |
v3 | 2019-11-16 | English | Compare |
v2 | 2019-11-14 | French | Compare |
v1 | 2019-11-14 | English | Compare |
Showing 1 to 8 of 8